Skip to main content

Policy

The FDA announced it is now receiving public comments on the development and evaluation of abuse-deterrent formulations of central nervous system stimulants and whether such products could play a role in addressing public health concerns over prescription stimulant misuse.
Fentanyl overdose deaths climbed 14% in 2018, per CDC data, and a report released this week by not-for-profits Drug Strategies and Shatterproof studies the states hit hardest and how they have responded.
The first supervised injection facility in the United States is one step closer to opening after a U.S. district judge ruled that a Philadelphia not-for-profit’s project does not violate federal drug laws.
During its 15th annual Hill Day in Washington, D.C., the National Council for Behavioral Health unveiled a five-pronged campaign to expand access to treatment, enforce parity laws and grow the mental health and addiction treatment workforce.
A report from the American Medical Association and Manatt Health suggests that Medicaid expansion states have a significant advantage in combating the opioid epidemic.

ONC fellow discusses current privacy initiatives being explored in federal health IT effort

Back to Top